Rationale and protocol of MetNET-2 trial: Lanreotide Autogel plus metformin in advanced gastrointestinal or lung neuroendocrine tumors

S. Pusceddu, N. Prinzi, G. Lo Russo, D. Femia, M. Milione, F. Perrone, E. Tamborini, L. Concas, I. Pulice, C. Vernieri, F. Corti, R. Buzzoni, F. De Braud

Research output: Contribution to journalArticlepeer-review

Original languageUndefined/Unknown
Pages (from-to)1677-1683
Number of pages7
JournalFuture Oncology
Issue number19
Publication statusPublished - 2017

Cite this